Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.35% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTOutset Medical, Inc.'s latest supported as-filed period reports revenue of $31.6M; gross margin moved 422 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.35% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -30.46% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 0.69% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 149.57% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 41.99% · CORE
Level · gp.fundamentals.operating_margin
Raw value -49.55% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -11.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross margin changed +422 basis points from the comparable as-filed period.
Gross profit changed +11.9% from the comparable as-filed period.
Inventory changed -9.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
OM · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001484612-26-000050SEC ↗4Aug 18, 2026Period Aug 17, 20260001484612-26-000048SEC ↗4Aug 18, 2026Period Aug 17, 20260001484612-26-000047SEC ↗10-QAug 6, 2026Period Jun 30, 20260001193125-26-338432SEC ↗8-KAug 6, 2026Period Aug 6, 20260001193125-26-337953SEC ↗4Jun 29, 2026Period Jun 26, 20260001484612-26-000045SEC ↗4Jun 29, 2026Period Jun 26, 20260001484612-26-000043SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 17, 2026Filed Aug 18, 2026 | Trigg LeslieChair and CEO | Open Market SaleDirect | 3,437 | $4 | $15,088 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 17.23% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 8.52% · OPTIONAL
Net income changed +3.0% from the comparable as-filed period.
Operating income changed +7.1% from the comparable as-filed period.
Operating margin changed +413 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001484612-26-000041